Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 4136.08 | 459 / 459 | 100% | 75.87 | 1118 / 1118 |
esophagus | 100% | 3719.81 | 1445 / 1445 | 100% | 65.22 | 183 / 183 |
lung | 100% | 3464.12 | 578 / 578 | 100% | 51.16 | 1155 / 1155 |
ovary | 100% | 3324.52 | 180 / 180 | 100% | 37.68 | 430 / 430 |
prostate | 100% | 4277.74 | 245 / 245 | 100% | 53.36 | 501 / 502 |
brain | 100% | 3740.19 | 2636 / 2642 | 100% | 36.98 | 705 / 705 |
stomach | 100% | 2641.26 | 359 / 359 | 100% | 40.49 | 285 / 286 |
bladder | 100% | 4084.48 | 21 / 21 | 99% | 45.64 | 501 / 504 |
uterus | 100% | 3643.83 | 170 / 170 | 99% | 47.75 | 456 / 459 |
intestine | 100% | 3468.90 | 966 / 966 | 99% | 40.15 | 523 / 527 |
thymus | 100% | 3437.36 | 653 / 653 | 99% | 35.13 | 600 / 605 |
kidney | 100% | 2664.31 | 89 / 89 | 98% | 31.77 | 887 / 901 |
skin | 100% | 4822.04 | 1809 / 1809 | 98% | 50.96 | 461 / 472 |
pancreas | 99% | 1707.95 | 325 / 328 | 98% | 34.85 | 175 / 178 |
liver | 100% | 2143.88 | 226 / 226 | 97% | 27.30 | 394 / 406 |
adrenal gland | 100% | 3902.86 | 258 / 258 | 94% | 35.67 | 217 / 230 |
adipose | 100% | 4350.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4175.46 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 44.96 | 29 / 29 |
muscle | 100% | 5655.30 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2764.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 50.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.35 | 1 / 1 |
heart | 96% | 2680.21 | 830 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 18.84 | 66 / 80 |
peripheral blood | 62% | 2077.03 | 572 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
GO_0045087 | Biological process | innate immune response |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0050920 | Biological process | regulation of chemotaxis |
GO_1904293 | Biological process | negative regulation of ERAD pathway |
GO_0016579 | Biological process | protein deubiquitination |
GO_0061136 | Biological process | regulation of proteasomal protein catabolic process |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000502 | Cellular component | proteasome complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0101005 | Molecular function | deubiquitinase activity |
GO_0070628 | Molecular function | proteasome binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0004866 | Molecular function | endopeptidase inhibitor activity |
GO_0061578 | Molecular function | K63-linked deubiquitinase activity |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | USP14 |
Protein name | Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14) Ubiquitin specific peptidase 14 Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) |
Synonyms | TGT |
Description | FUNCTION: Proteasome-associated deubiquitinase which releases ubiquitin from the proteasome targeted ubiquitinated proteins . Ensures the regeneration of ubiquitin at the proteasome . Is a reversibly associated subunit of the proteasome and a large fraction of proteasome-free protein exists within the cell . Required for the degradation of the chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis . Serves also as a physiological inhibitor of endoplasmic reticulum-associated degradation (ERAD) under the non-stressed condition by inhibiting the degradation of unfolded endoplasmic reticulum proteins via interaction with ERN1 . Indispensable for synaptic development and function at neuromuscular junctions (NMJs) (By similarity). Plays a role in the innate immune defense against viruses by stabilizing the viral DNA sensor CGAS and thus inhibiting its autophagic degradation . Inhibits OPTN-mediated selective autophagic degradation of KDM4D and thereby negatively regulates H3K9me2 and H3K9me3 . . FUNCTION: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes. . |
Accessions | ENST00000400266.7 [P54578-3] ENST00000581983.1 ENST00000261601.8 [P54578-1] R4GNB0 A6NJA2 J3KS55 ENST00000383589.6 ENST00000580410.5 ENST00000582707.5 [P54578-2] P54578 ENST00000583119.5 J3QQT6 |